LVTX a possible continuation medical technology penny stock LONG

LVTX is a pharmaceutical company focused on biologicals for advanced prostate carcinoma.

It recently secured a collaboration agreement with Merck to assist in the clinical trials and

the financial burdens it imposes in a quid pro quo related to a share of product margins in the

future. On the 15-minute chart, LVTX burst out of a long-standing consolidation cycle. The

majority of shareholders per Yahoo Finance are insiders and institutions primarily hedge funds.

These people are not clueless. This is a huge money inflow into the market cap. I intend

to follow the money as I see that price has retraced to a good Fibonacci level and with the

last candle may be on a reversal. I know that institutions tend to buy at the VWAP heavily

and as price is below VWAP the impetus is to buy discounted from VWAP. I will follow

the wisdom, experience and expertise of institutional traders. I will go long and assume the

risk of more of a drop with an ATR stop loss. My goal in the trade is to get a 20% gain by the

close on Monday. Getting into an insider trading move is tricky but it is interesting and

can be profitable.

Trade closed: stop reached:

Stopped out with a 5% loss. Will add to the watch list.